2020MDS ANNUAL MEETING

Transcription

2020MDSAN NUALMEETINGDENVER, COLORADOThursday, March 19, 2020

LIVING WITH PERSISTENTPEMPHIGUS?THE PEGASUS TRIAL IN PEMPHIGUS VULGARIS (PV)AND PEMPHIGUS FOLIACEUS (PF) IS NOW ENROLLINGPrincipia Biopharma is conducting a Phase 3 clinical trial of an investigational drug (PRN1008, an oral pill).PRN1008 is a Bruton’s tyrosine kinase (BTK) inhibitor which may improve pemphigus. This trial is beingdone to see if PRN1008 is safe and can achieve disease remission (clear skin with no blisters) with reducedcorticosteroids.PEGASUS TRIAL DETAILS Over 18 years of age Newly diagnosed or relapsing PV and PF patients with moderate to severe disease Length of the trial for each patient is about 17 months Reimbursement for travel may be available (talk to your Trial Doctor) Clinical Sites are open globally, including US & Canada ClinicalTrials.gov (NCT03762265)FIND OUT ABOUT A CLINICAL TRIAL SITE IN YOUR AREAEMAIL: clinicaltrials@principiabio.comPHONE: 1-833-477-6700 2017, 2019 Principia Biopharma. All Rights Reserved.2

President’s LetterDear Members:On behalf of the Medical Dermatology Society (MDS) Board of Directors, I would like to welcomeyou to the 2020 Annual Meeting, this meeting marks the 25th year of the organization.The MDS continues to grow and remains ever adaptable, motivated, and responsive to addressing the needs of ourpatients and to growing the field of medical dermatology. The MDS is also committed to sharing knowledge, facilitatingcollaborative opportunities, and supporting the development of inspired dermatologists who will advance our specialty.With these objectives in mind, I am delighted to present to you 1) an update on our collaborative research efforts and 2)our Annual Meeting’s Scientific Program.Many of the diseases we treat carry significant potential morbidity and mortality. Yet, they are rare and difficult to study.You may recall that last year marked the first meeting of the MDS Research Working Group, whose goal is to tackle theseissues through collaborative research throughout the year. The Research Working Group is continuing to meet and isplanning cooperative efforts to push this initiative forward in a tangible way. Progress is being made and I am very excitedto see where this takes our field.The 25th Anniversary Program is exemplary and aims to highlight topics central to the practice of the medical dermatologist.The meeting planners have worked diligently to provide an educational experience that speaks to the advancementsmade in medical dermatology since the launch of the MDS 25 years ago. To begin, the abstracts presented this year areof particularly superb quality and were chosen from over 125 submissions! Multiple mini-keynote talks, covering a rangeof diseases, will be delivered by experts in those fields. Dr. Edward Cowen will discuss Graft vs Host disease, Dr. RobertMicheletti will focus on Stevens Johnson Syndrome and Toxic Epidermal Necrolysis, Dr. William McCoy will offer insighton the role of the microbiome in dermatology, and Dr. John Harris will present what is new in Vitiligo. Master cliniciansDr. Kathryn Schwarzenberger and Dr. Lela Lee will each offer pearls essential to the practicing medical dermatologist.This meeting denotes a very special milestone in the tenure of the MDS. To mark this special occasion, MDS founder’sDr’s. Jeffrey Callen, Richard Sontheimer and Victoria Werth will share with us their reflections on the MDS from its inceptionto current times.Finally, we look forward to celebrating the accomplishments and contributions of Master Clinician and MedicalDermatologist Dr. Timothy Berger, this year’s very deserving Lifetime Achievement Award Recipient.I would like to thank the members of the MDS Committees and Board who have worked throughout the year to ensure aquality meeting.Thank you for attending the MDS Annual Meeting and bringing your expertise and passion to our gathering. As leadersin the field of medical dermatology, you have the vision, knowledge, and drive to propel our mission ahead. You are trulyour greatest asset and we could not accomplish what we do without your support. If you have any questions regardingany MDS activities, please do not hesitate to reach out to me directly or to our administrative office. Welcome to Denver,Colorado and the 25th Anniversary of the MDS Annual Meeting.Sincerely,Lindy P. Fox, MDPresident, MDS3

History and MissionThe Medical Dermatology Society (MDS) is made up of thethought leaders in clinical dermatology and the teachersof the next generation of practicing dermatologists. TheMDS mission is to improve the care of patients whoseskin diseases or therapies have substantial systemicconsequences; foster research in medical dermatologyand assure medical dermatology expertise in communityand academic settings.Members of the MDS represent the heart and soul of ourspecialty: Medical Dermatology. Founded in 1994, ourmembers include Academicians, Private Practitioners andResident Physicians who specialize in the care of patientswith dermatologic diseases.The MDS is a physician organization dedicated to: Advancing the understanding and treatment ofserious dermatologic diseases through education andresearch; Exchanging advancesdermatology;inthefieldofmedical Promoting the training of dermatology residents,fellows and practitioners in the pathogenesis andtreatment of complex dermatologic diseases.Target Audience and Symposium Description andLearning ObjectivesThis course is designed for physicians in the followingspecialties: Dermatology, Internal Medicine andDermatopathology. Session will encourage all participantsof this activity to implement some of the new informationand/or techniques into their practice. Encourageparticipants to change as a result of attending this activity.In this educational program, we will address the followingpractice base challenges and problems:1. Investigate and evaluate patient care practices inmedical dermatology2. Appraise and assimilate scientific evidence for thetreatment of patients with complex medical dermatologyissues3. Implement evidence based diagnostic and therapeuticalgorithms for patients with Vitiligo, Graft vs Host Disease(GvHD), Stevens-Johnson Syndrome/Toxic EpidermalNecrolysis (SJS/TEN)Demonstrate knowledge about established and evolvingbiomedical, clinical and cognate sciences and theirapplication in patient care. Investigate and evaluatepatient care practices, appraise and assimilate scientificevidence and improve practice of medicine.Identify errors and hazards in care; understand andimplement basic safety design principles; continuallyunderstand and measure quality of care in terms ofstructure, process and outcomes in relation to patientand community needs; design and test interventions tochange processes and systems of care with the objectiveof improving quality.Communicate, manage knowledge, mitigate error, andsupport decision making using information technology.This activity will provide educational content aimed atclosing the defined gap to result in improved knowledge,competence, and/or performance, which could result inimproved patient outcomes.University of Iowa Joint Provider StatementThis activity has been planned and implemented inaccordance with the accreditation requirements andpolicies of the Accreditation Council for ContinuingMedical Education (ACCME) through the joint providershipof the University of Iowa Carver College of Medicine andthe Medical Dermatology Society. The Carver College ofMedicine is accredited by the ACCME to provide continuingmedical education for physicians.4The University of Iowa Carver College of Medicinedesignates this live activity for a maximum of 4.0 AMA PRACategory 1 Credit(s) . Physicians should claim only thecredit commensurate with the extent of their participationin the activity.

2019 - 2020 Medical Dermatology SocietyBoard and Committee MembersOfficersEducation and ProgramsCommitteeMembershipCommitteeLINDY FOX, MDPresident2018-2020University of California, San FranciscoMILAN ANADKAT, MD, Chair2017-2022Washington University School of Medicinein St. LouisADELA RAMBI CARDONES, MD, Chair2016-2021Duke University School of MedicineMISHA ROSENBACH, MDPresident Elect2018-2020University of PennsylvaniaGIDEON SMITH, MD, PhD, Co-Chair2018-2023Massachusetts General Hospital, HarvardMedical SchoolVINOD NAMBUDIRI, MDSecretary-Treasurer2018-2021Brigham and Women’s Hospital, GrandStrand Medical CenterEDWARD W. COWEN, MD, MHSc2018-2021National Institute of Arthritis andMusculoskeletal and Skin Diseases (NIAMS)NICOLE FETT, MD, MSCE2017-2020Oregon Health and Sciences UniversityDirectorsAMRITA GOYAL-O’LEARY, MD2018-2020 / Resident TermUniversity of MinnesotaMILAN ANADKAT, MD2017-2022Washington University School ofMedicine in St. LouisWILLIAM HUANG, MD, MPH2017-2020Wake Forest UniversityADELA RAMBI CARDONES, MD2016-2021Duke University School of MedicineTARANNUM JALEEL, MD2019-2022Duke University School of MedicineJONATHAN COTLIAR, MD2015-2020Harbor-UCLA Medical CenterDREW KURTZMAN, MD2017-2020St. Elizabeth Physicians, Dermatology &AestheticsART SAAVEDRA, MD, PHD, MBA2019-2024University of Virginia Schoolof MedicineART SAAVEDRA, MD, PHD, MBA, Co-Chair2019-2024University of Virginia School of MedicineROBERT MICHELETTI, MD2018-2021University of PennsylvaniaTARANEH PARAVAR, MD2017-2020University of California, San DiegoALAN ZHOU, MD2019-2022Northwestern University,Feinberg School of MedicineFinance CommitteeJONATHAN COTLIAR, MD, Chair2015-2020Harbor-UCLA Medical CenterSTEVEN CHEN, MD2017-2020Massachusetts General Hospital,Harvard Medical SchoolJENNIFER CHOI, MD2018-2021Northwestern University,Feinberg School of MedicineEMILY L. KEIMIG, MD2019-2022Northwestern University,Feinberg School of MedicineGIDEON SMITH, MD, PhD2018-2023Massachusetts General Hospital,Harvard Medical SchoolVINOD NAMBUDIRI, MDSecretary-Treasurer (ex-officio)2018-2021Brigham and Women’s Hospital, GrandStrand Medical Center5

2020 ANNUAL MEETING of the MEDICAL DERMATOLOGY SOCIETY12:30 PMINTRODUCTION AND WELCOMELindy Fox, MD, President, Medical Dermatology Society;Professor of Dermatology, University of California, San FranciscoMDS Business MeetingMDS Mentorship Awardees Announcement12:55 PMCarla Sparkler Research Scholarship Young Investigators Award1:00-2:00 PMABSTRACT PRESENTATIONSPresiding:Milan Anadkat, MD, Washington University School of Medicine in St. Louis1:00-1:12 PMNecrobiotic xanthogranuloma: Multi-center cross-sectional study,systematic review, and proposed diagnostic criteriaCaroline Nelson, MDYale University1:12-1:24 PMPerioperative management of pyoderma gangrenosumAlex Ortega-Loayza, MDOregon Health & Science University1:24-1:36 PMAssessment of outcomes of calciphylaxis treated with intralesionalsodium thiosulfateColleen Gabel, BSMassachusetts General Hospital1:36-1:48 PMOutcomes of immune checkpoint inhibitor re-challenge in melanomatreatment after high grade immune related adverse eventsPayal Shah, BSNew York University Langone Health1:48-2:00 PMAccuracy of commercial myositis panels: A single-institution perspectiveAdarsh Ravishankar, BSUniversity of Pennsylvania2:00-2:25 PMMINI KEYNOTE #1 GRAFT-VERSUS-HOST DISEASE (GvHD)Edward W. Cowen, MD, MHScNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2:25-2:55 PMAbstract Viewing / Break2:55-3:25 PMMINI KEYNOTE #2 STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS (SJS/TEN)Robert G. Micheletti, MDUniversity of Pennsylvania, Perelman School of Medicine3:25-3:40 PM25th ANNIVERSARY OF THE MEDICAL DERMATOLOGY SOCIETYApproaches taken and where we are nowJeffrey P. Callen, MD, FACP, FAAD, MACRProfessor of Medicine, Chief, Division of Dermatology, University of Louisville School of MedicineThe Medical Dermatology Society: Reflections from the Society’s FounderVictoria P. Werth, MDChief, Dermatology, Philadelphia V.A. Hospital; Professor of Dermatology and Medicine at theHospital of the University of Pennsylvania and the Veteran’s Administration Medical Center6

2020 ANNUAL MEETING of the MEDICAL DERMATOLOGY SOCIETY3:40-4:05 PMMINI KEYNOTE #3 MICROBIOMEPOINT-OF-CARE SKIN MICROBIOME TESTS: THE POTENTIAL APPLICATIONS IN ACNE VULGARISWilliam H. McCoy IV, MD, PhDResearch Instructor, Washington University School of Medicine4:05-4:35 PMCLINICAL PEARLS #1THOSE THAT TEACH USKathryn Schwarzenberger, MDProfessor of Dermatology, School of Medicine, Oregon Health & Science University4:35-4:55 PMAbstract Viewing / Break4:55-5:20 PMMINI KEYNOTE #4 VITILIGONEW TREATMENT OPPORTUNITIES IN VITILIGOJohn E. Harris, MD, PhDAssistant Professor, University of Massachusetts Medical SchoolDirector, Vitiligo Clinic and Research Center at University of Massachusetts Medical School5:20-5:50 PMCLINICAL PEARLS #2LESSONS LEARNED BY A PGY40Lela A. Lee, MDClinical Professor of Dermatology and Medicine, University of Colorado6:00 PM2020 MDS LIFETIME ACHIEVEMENT AWARDTIMOTHY BERGER, MDProfessor, University of California, San FranciscoPresented by6:15 PMBruce Wintroub, MDVice Dean of the School of Medicine, Dermatology Chair, Dermatology ProfessorUniversity of California, San FranciscoNetworking Reception7

Medical Dermatology SocietyLifetime Achievement Award Recipients2019JANET A. FAIRLEY, MD, FAADUniversity of Iowa Health Care2018WARREN R. HEYMANN, MDCooper Medical School of Rowan UniversityPerelman School of Medicine at the University of Pennsylvania2017RUSSELL P. HALL, MDDuke University Medical Center2016JEAN BOLOGNIA, MDYale University School of Medicine2015WILLIAM JAMES, MDUniversity of Pennsylvania2014LUIS A. DIAZ, MDUniversity of North Carolina, Chapel Hill2013RICHARD D. SONTHEIMER, MDUniversity of Utah Health Care2012GERALD G. KRUEGER, MDUniversity of Utah Health Care2011JEFFREY P. CALLEN, MDUniversity of Louisville School of Medicine2010VICTORIA P. WERTH, MDUniversity of Pennsylvania2009HARLEY A. HAYNES, MDBrigham and Women’s Hospital2008KENNETH E. GREER, MDUniversity of Virginia2007LEE T. NESBITT, JR., MDLouisiana State University Health Sciences Center2006SAMUEL MOSCHELLA, MDLahey Hospital and Medical Center2005THOMAS T. PROVOST, MDJohns Hopkins Hospital2004IRWIN M. BRAVERMAN, MDYale University School of Medicine8

MEDICAL DERMATOLOGY SOCIETYPRESENTS THE2020Lifetime Achievement AwardTimothy Berger, MDProfessorUniversity of California, San Francisco

2019 MDS SUSTAINING MEMBERSA Special Thank You To All Who HaveGenerously Contributed To The MDS!MURAD ALAM, MDNorthwestern University, Feinberg School of MedicineJAMI MILLER, MDVanderbilt University Medical CenterLAURA ASPEY, MD, MPHEmory UniversityDEDEE MURRELL, MD, PhDSt George Hospital, University of New South WalesSYLVIA BRICE, MDDenver Health Medical CenterMARTA PETERSEN, MDUniversity of UtahMARIA COLAVINCENZO, MDNorthwestern University, Feinberg School of MedicineABRAR QURESHI, MD, MPHBrown Dermatology, Inc.KRISTINA CALLIS DUFFIN, MD, MSUniversity of UtahKANADE SHINKAI, MD, PhDUniversity of California, San FranciscoKARYNNE DUNCAN, MDDuncan DermatologyWILLIAM TSIARAS, MD, PhDBrigham and Women’s HospitalMICHAEL HEFFERNAN, MDSan Luis Dermatology and Laser ClinicRUTH ANN VLEUGELS, MD, MPHBrigham and Women’s Hospital, Harvard Medical SchoolANNE LAUMANN, MD, MBChB, MRCP (UK)Northwestern University, Feinberg School of MedicineJONATHAN ZIPPIN, MDWeill Cornell Medical CollegeSANCY LEACHMAN, MD, PhDOregon Health & Science UniversityJOHN ZONE, MDUniversity of UtahKURT LU, MDNorthwestern University, Feinberg School of MedicineConsider Becoming aSustaining Memberof the MDSJoin us to make a difference within asmall membership societyContact the MDS office directly 216.579.9300or visit www.meddermsociety.org10

Thank You To Our Members For Their GenerousContributions To The Mentorship Program!MURAD ALAM, MDNorthwestern UniversityWARREN HEYMANN, MDCooper Medical School of Rowan UniversityJEFFREY CALLEN, MDUniversity of LouisvilleCHRISTOPHER RICHARDSON, MD, PhDUniversity of RochesterNICOLE FETT, MD, MSOregon Health & Science UniversityNATHAN ROJEK, MDUniversity of California, IrvineANNA HAEMEL, MDUniversity of California, San FranciscoKAROLYN WANAT, MDMedical College of WisconsinA Sincere Thank You To All Members WhoHave Generously Sponsored Medical Students/Residents/Post-Doctoral FellowsEMILY M. ALTMAN, MD, FAADUniversity of New MexicoLELA A. LEE, MDAmerican Board of DermatologyJEAN BOLOGNIA, MDYale UniversityARASH MOSTAGHIMI, MD, MPA, MPHBrigham and Women’s HospitalJEFFREY CALLEN, MDUniversity of LouisvilleVINOD NAMBUDIRI, MDBrigham and Women’s HospitalNICOLE FETT, MDOregon Health & Science UniversityCAROLINE NELSON, MDYale New Haven HospitalDAVID FIVENSON, MDDavid Fivenson, MD, Dermatology, PLLCNATHAN ROJEK, MDUniversity of California, IrvineLINDY FOX, MDUniversity of California, San FranciscoMISHA ROSENBACH, MDUniversity of PennsylvaniaANNA HAEMEL, MDUniversity of California, San FranciscoKATHLEEN Y. SAWADA, MDAccent Dermatology and Laser InstituteHARLEY HAYNES, MDBrigham and Women’s HospitalKANADE SHINKAI, MD, PhDUniversity of California, San FranciscoWILLIAM JAMES, MDUniversity of PennsylvaniaROBERT SWERLICK, MDEmory UniversityAVERY LaCHANCE, MD, MPHBrigham and Women’s HospitalDAVID WOODLEY, MDUniversity of Southern California11

THE MEDICAL DERMATOLOGY SOCIETYGratefully Acknowledgesfor their generous support of the2020 MDS Annual MeetingMEDICAL DERMATOLOGY SOCIETYExtends its gratitude toCarla Sparklerfor her generous philanthropic support of our mission toconduct research, teach, and provide care for patientswith the most challenging diseases in dermatology.The CARLA SPARKLER SCHOLARSHIP, a new fundinginitiative as part of our Research Awards Program,the first program of its kind dedicated exclusivelyto funding young investigators with their medicaldermatology research.Carla Sparkler is a medical professional dedicatedto the advancement of science and helping youthattain their dreams and further their medicalprofessions. She believes in mentoring youngpeople and helping them grow and become leadersand managers.She leads by example and loves helping people whowork for her become better people by providingactive help and support. She is one of the hardestworkers you will ever meet and will challenge you tothink critically, provide solid arguments, and supporta common goal of constant growth.

BioTek reMEDys is a leading specialty pharmacyproviding medications and supportservices topatients, physicians, nurses, payers and pharma.Our Immunoglobulin Therapy program is designedto help your clinical team achieve their individualpatient goals. BioTek reMEDys communicates witheach clinical practice ensuring that each patientsexperience is optimal.We assist office staff andpatients navigate investigation of benefits, pharmacynetworks, drug formularies and medical policies. WeWhere ThePatient Comesprovide experienced infusion nurses who help care forand teach patients while supporting prescriber infusionprotocols. Together BioTek reMEDys will collaborate toimprove patients’ compliance, adherence, satisfactionand outcomes!FIRST.The faculty and residents of the Department of Dermatology of the Keck School of Medicine ofthe University of Southern California (USC) send our congratulations to Dr. Timothy Berger asthe 2020 recipient of the MDS Lifetime Achievement Award – a fitting honor for thisoutstanding academic dermatologist who has advanced our beloved specialty.We also invite MDS members to visit the USC Department of Dermatology and one of oursub-specialty clinics: melanoma and pigment diseases (Dr. David Peng and Dr. Binh Ngo),autoimmune bullous diseases (Dr. David T. Woodley), skin lymphoma (Dr. Brittney DeClerck),skin of color (Dr. Nada Elbuluk), skin and connective tissue diseases (Dr. Ashley Crew),environmental dermatology and contact allergy (Dr. Vincent DeLeo), Hansen’s Disease clinic(Dr. Maria Teresa Ochoa), pediatric dermatology (Dr. Minelli Luu, Dr. Stefani Takahashi, Dr.Meagan Hughes, and Dr. Nicole Harter), AIDS/HIV clinic (Dr. David Sawcer, Dr. Ilya Reyter,Dr. Iris Ahronowitz), and inpatient and complex medical dermatology (Dr. Scott Worswick andDr. David Peng).USC Dermatology13

CongratulationsMDSon your 25th Birthday!Jeffrey P. Callen, MDImproving the livesof and empoweringthose fighting myositis.Myositis Support and Understanding Association (MSU), founded in 2015, is apatient-led, all-volunteer nonprofit organization whose mission is to improvethe lives of and empower those fighting myositis through education, support,awareness, advocacy, financial assistance, and access to research.MSU also works together with physicians, scientists, and researchers to help educate patients and caregivers, and will begin funding small research projectsfocused on what matters most to patients.With a patient and caregiver support network of over 10,000 people, and growing daily, we invite you to join us to learn more about the patient experience andhow we can work together to promote education, research, and overall awareness about myositis.Visit our comprehensive myositis website at Understandingmyositis.org and ournewest website, #MyositisLIFE, which is a community-focused website sharingpatient and caregiver submitted experiences that show the realities of living withthe rare group of diseases, myositis. Visit MyositisLife.org.14

Congratulations tothe Medical DermatologySociety on it’s 25thanniversary!The Department ofDermatology at the MedicalCollege of Wisconsinprovides exceptional andcompassionate care forchildren and adults withcommon and complexskin diseases. We educateclinicians and future leaderswho will advance thespeciality of dermatologyand foster innovative andinterdisciplinary SITY OF UTAHDERMATOLOGYPROUDLY SUPPORTINGTHE MEDICALDERMATOLOGY SOCIETYFOR 25 YEARS15

IT’S TIME TOLEARN MOREVisit DupixentHCP.com 2020 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.DUP.20.02.008516

The UCSF Department of Dermatology congratulatesTim Berger, MDas the 2020 Recipient of the Medical Dermatology SocietyLifetime Achievement Award17

Save the DateMARCH 18, 20212021 ANNUAL MEETINGSanFranciscoC A L I F O R N I A

Brigham and Women’s Hospital/Harvard Medical School Offers 4 Fellowships beginning July 1, 2021. Interestedapplicants should send a letter of interest along with a current CV to BWHDerm@bwh.harvard.edu. For moreinformation please visit our website at www.brighamandwomens.org/dermatology.Cutaneous Oncology Fellowship which is a one-year program that provides specialized training in the diagnosisand management of cutaneous malignancies. It is targeted towards dermatologists who want to gain proficiencyin the latest therapies and principles involved in the management of patients with a broad range of skin cancersincluding melanoma, cutaneous lymphomas, Merkel cell carcinoma, high risk basal and squamous cell cancers,and a number of rare malignancies. Program Director: Nicole LeBoeuf, MD, MPH.Dermatology/Rheumatology Fellowship program. The Fellow will develop expertise in the diagnosis andmanagement of a wide range of connective tissue diseases, including cutaneous lupus, dermatomyositis,scleroderma, psoriasis, and vasculitis. The program will include the full spectrum of clinical management, fromlearning unique physical exam skills to aid in clinical diagnosis to gaining familiarity with systemic therapeutics.A multi-disciplinary approach will be utilized, and the Fellow will work closely with both dermatologists andrheumatologists. The Fellow’s career development will be a primary goal of the year-long fellowship. Opportunitiesfor clinical and translational research as well as dedicated elective time will also be available to the Fellow. ProgramDirector: Ruth Ann Vleugels, MD, MPH.Contact Dermatitis and Occupational Dermatology Fellowship. This is a unique, year-long Fellowship which is oneof a handful of advertised Contact Dermatitis Fellowships in the United States. This Fellowship is the only one inthe States to offer the breadth and depth of exposure to many fields impacting the study of contact dermatitis.Fellows will rotate in the BWH Allergy/Immunology Department, Occupational Medicine Clinics, Dermatopathologylaboratory, Immunology/T-cell research laboratories, Phototherapy Clinic, Genital Dermatology Clinic, OralMedicine Department, as well as complex medical dermatology clinics. Program Director: Pamela Scheinman, MD.Complex Medical Dermatology Fellowship Program. This fellowship prepares trainees to be leaders in themanagement of patients with complex medical dermatology illnesses. Fellows will master physical exam skillsand develop expertise with the use of emerging systemic therapeutics and management of their side effects. TheFellow will rotate on the Inpatient Dermatology Consult Service and through ambulatory clinics that specializein supportive oncodermatology, post-discharge dermatology, skin and rheumatic diseases, bullous disease, graftversus host disease, infectious disease, and wounds. Each fellow’s curriculum is modified based on their priorexperience and career goals. Program Director: Arash Mostaghimi, MD, MPA, MPH.All fellows will have the opportunity to participate in didactic sessions, Grand Rounds and other educationalopportunities within the Harvard system. They will pursue a clinical research project and are encouraged topublish their results when appropriate.19

Do you want to make thetreatment of psoriasis morepatient centered?Do you offer NB UVB phototherapy? Join us today!We invite you to collaborateThe LITE Study, a large pragmatic randomized active comparatorstudy of home vs. office-based phototherapy, is now recruiting sites.We invite you to join this groundbreaking study, which could leadto better treatments and outcomes for hundreds of thousands ofphototherapy candidates.Details at thelitestudy.comThe LITE Study is funded by the Patient-Centered Outcomes Research Institute, which funds comparativeclinical effectiveness research studies that focus on outcomes impor tant to patients.Enroll your site at 01092019.indd 11/11/2019 9:00:43 AM20

of diseases, will be delivered by experts in those fields. Dr. Edward Cowen will discuss Graft vs Host disease, Dr. Robert Micheletti will focus on Stevens Johnson Syndrome and Toxic Epidermal Necrolysis, Dr. William McCoy will offer insight on the role of the microbiome in dermatology, and Dr. John Harris will present what is new in Vitiligo.